As further validation of E2F1–3 regulating LT/ST transcription in MCC cells, we treated MKL-1 and MKL-2 cells with a small molecule E2F inhibitor (HLM006474) and assessed its effects on LT/ST mRNA and protein expression (Fig. 1F&G). Here, E2F1 is linked to Merkel cell skin cancer.